Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for ICLR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 928.38M
March 31, 2026 765.16M
December 31, 2025 647.30M
September 30, 2025 468.89M
June 30, 2025 390.40M
March 31, 2025 526.70M
December 31, 2024 538.78M
September 30, 2024 695.51M
June 30, 2024 506.55M
March 31, 2024 398.04M
December 31, 2023 380.06M
September 30, 2023 315.02M
June 30, 2023 271.83M
March 31, 2023 281.53M
December 31, 2022 290.48M
September 30, 2022 610.87M
June 30, 2022 616.63M
March 31, 2022 560.81M
December 31, 2021 753.92M
September 30, 2021 1.010B
June 30, 2021 1.057B
March 31, 2021 944.18M
December 31, 2020 842.03M
September 30, 2020 709.72M
June 30, 2020 593.83M
Date Value
March 31, 2020 484.10M
December 31, 2019 569.94M
September 30, 2019 471.24M
June 30, 2019 431.28M
March 31, 2019 477.94M
December 31, 2018 455.76M
September 30, 2018 491.48M
June 30, 2018 373.00M
March 31, 2018 353.54M
December 31, 2017 360.45M
September 30, 2017 292.48M
June 30, 2017 314.92M
March 31, 2017 318.97M
December 31, 2016 260.59M
September 30, 2016 303.72M
June 30, 2016 250.95M
March 31, 2016 247.86M
December 31, 2015 189.90M
September 30, 2015 316.99M
June 30, 2015 192.20M
March 31, 2015 191.68M
December 31, 2014 216.00M
September 30, 2014 248.61M
June 30, 2014 175.37M
March 31, 2014 363.52M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
IQVIA Holdings, Inc. 2.08B
Medpace Holdings, Inc. 502.69M
Proteome Sciences Plc --
Champions Oncology, Inc. 4.872M
Avantor, Inc. 306.80M